AB Science S.A. (OTCMKTS:ABSCF) Short Interest Up ? in July

AB Science S.A. (OTCMKTS:ABSCF) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totaling 961 shares, an increase of ? from the June 30th total of 0 shares. Based on an average daily volume of 40 shares, the short-interest ratio is presently 24.0 days.

AB Science Stock Performance

ABSCF opened at $1.12 on Thursday. The business has a 50 day moving average price of $1.12 and a two-hundred day moving average price of $1.30. AB Science has a 1-year low of $1.12 and a 1-year high of $1.37.

AB Science Company Profile

AB Science is a clinical-stage biotechnology company headquartered in Paris, France, specializing in the discovery and development of protein kinase inhibitors. Its core focus is on the design of orally administered small-molecule therapies that target key signaling pathways involved in oncology, inflammatory disorders and neurodegenerative diseases. The company’s lead asset, masitinib, is a selective tyrosine kinase inhibitor that has been evaluated in multiple Phase 2 and Phase 3 clinical trials, including studies in mastocytosis, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and severe asthma.

Since its founding in 2001 by Dr.